Artal Group S.A. Apellis Pharmaceuticals, Inc. Transaction History

Artal Group S.A.

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$38.07 - $59.71 $5.78 Million - $9.06 Million	151,798 Added 11.54%	1,467,080 $56.3 Million
Q1 2024 May 13, 2024	SELL	$55.39 - $72.47 $5.87 Million - $7.69 Million	-106,064 Reduced 7.46%	1,315,282 $77.3 Million
Q4 2023 Feb 09, 2024	SELL	$37.14 - $64.82 $9.03 Million - $15.8 Million	-243,226 Reduced 14.61%	1,421,346 $85.1 Million
Q3 2023 Nov 13, 2023	BUY	$23.65 - $89.22 $14.5 Million - $54.8 Million	614,505 Added 58.52%	1,664,572 $63.3 Million
Q2 2023 Aug 11, 2023	SELL	$76.68 - $93.31 $12.7 Million - $15.5 Million	-166,245 Reduced 13.67%	1,050,067 $95.7 Million
Q1 2023 May 12, 2023	BUY	$46.59 - $66.96 $14.7 Million - $21.2 Million	316,312 Added 35.15%	1,216,312 $80.2 Million
Q4 2022 Feb 13, 2023	SELL	$43.24 - $61.04 $4.32 Million - $6.1 Million	-100,000 Reduced 10.0%	900,000 $46.5 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $44.8 Million - $69.7 Million	1,000,000 New	1,000,000 $68.3 Million
Q2 2022 Aug 11, 2022	SELL	$35.07 - $59.21 $7.01 Million - $11.8 Million	-200,000 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$35.46 - $54.12 $7.09 Million - $10.8 Million	200,000 New	200,000 $10.2 Million
Q2 2019 Aug 09, 2019	SELL	$18.0 - $25.34 $5.4 Million - $7.6 Million	-300,000 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$12.81 - $19.82 $3.84 Million - $5.95 Million	300,000 New	300,000 $5.85 Million

310

113M

3.85M

1.09M

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.29B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

Get notified when there are updates to the investment portfolio of Artal Group S.A., based on Form 13F filings with the SEC.

Stay updated on Artal Group S.A. with notifications on news.